 | Up a level |
Dietrich, S., Pircher, A., Andrulis, M. A., Peyrade, F., Wendtner, C. -M, Gaehler, A., Follows, G., Dyer, M., Elter, T., Zeiser, R., Herrmann, M., Herold, M., Dearden, C., Haferlach, T., Hallek, M., Huellein, J., Matutes, E., Duerig, J., von Kalle, C., Glimm, H., Froehling, S., Abdel-Wahab, O., Hutter, B., Steurer, M., Ho, A. and Zenz, T. (2015). Treatment of refractory hairy cell leukemia by BRAF-inhibition. Oncol. Res. Treat., 38. S. 119 - 120. BASEL: KARGER. ISSN 2296-5262
Follows, G., Fischer, K., Bosch, F., Frederiksen, H., Cuneo, A., Ludwig, H., Crompton, N., Maurer, J., Uguen, M., Fingerle-Rowson, G., Hallek, M. and Goede, V. (2016). An updated survival analysis from the CLL11 study in patients with chronic lymphocytic leukaemia treated with obinutuzumab or rituximab in combination with chlorambucil versus chlorambucil alone. Br. J. Haematol., 173. S. 95 - 96. HOBOKEN: WILEY-BLACKWELL. ISSN 1365-2141